| Cervical Cancer |
1 |
1 |
| Human Papillomavirus |
0 |
1 |
| Cytology |
0 |
0.87 |
| Triage |
0 |
0.33 |
| Cancer |
0 |
0.27 |
| Squamous Cell Carcinoma |
0 |
0.2 |
| Colposcopy |
0 |
0.17 |
| Biologic Therapy |
0 |
0.11 |
| Clinical Guidelines |
0 |
0.09 |
| Genomic Medicine |
0 |
0.09 |
| Preventive Screening |
0 |
0.09 |
| Referral |
0 |
0.09 |
| Medical Innovations |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Cervical Dysplasia |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Dysplasia |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| Methylation |
0 |
0.03 |
| Adenocarcinoma |
0 |
0.02 |
| Cervix |
0 |
0.02 |
| Electronic Medical Record |
0 |
0.02 |
| Food and Drug Administration (FDA) |
0 |
0.02 |
| Hysterectomy |
0 |
0.02 |
| Hysterectomy History |
0 |
0.02 |
| Immunocompromise |
0 |
0.02 |
| Immunohistochemistry |
0 |
0.02 |
| Pain |
0 |
0.02 |
| Papillomavirus |
0 |
0.02 |
| Polymerase Chain Reaction |
0 |
0.02 |
| Salary and Compensation |
0 |
0.02 |
| Vagina |
0 |
0.02 |
| Electronic Health Record (EHR) |
0 |
0.01 |
| Pain Management |
0 |
0.01 |
| Revenue and Practice Management |
0 |
0.01 |